Form 8-K - Current report:
SEC Accession No. 0001493152-25-001567
Filing Date
2025-01-10
Accepted
2025-01-10 08:30:38
Documents
52
Period of Report
2025-01-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 59045
2 ex4-3.htm EX-4.3 113320
3 ex5-1.htm EX-5.1 11012
4 ex10-1.htm EX-10.1 125005
5 ex99-1.htm EX-99.1 23384
6 ex99-2.htm EX-99.2 10512
7 ex99-3.htm EX-99.3 12391
8 ex5-1_001.jpg GRAPHIC 11375
9 ex99-1_001.jpg GRAPHIC 958899
10 ex99-1_002.jpg GRAPHIC 1645536
11 ex99-1_003.jpg GRAPHIC 1272558
12 ex99-1_004.jpg GRAPHIC 836393
13 ex99-1_005.jpg GRAPHIC 1364716
14 ex99-1_006.jpg GRAPHIC 898212
15 ex99-1_007.jpg GRAPHIC 937957
16 ex99-1_008.jpg GRAPHIC 1268490
17 ex99-1_009.jpg GRAPHIC 894172
18 ex99-1_010.jpg GRAPHIC 1221781
19 ex99-1_011.jpg GRAPHIC 1134317
20 ex99-1_012.jpg GRAPHIC 832220
21 ex99-1_013.jpg GRAPHIC 913260
22 ex99-1_014.jpg GRAPHIC 1007410
23 ex99-1_015.jpg GRAPHIC 1212655
24 ex99-1_016.jpg GRAPHIC 994952
25 ex99-1_017.jpg GRAPHIC 1095753
26 ex99-1_018.jpg GRAPHIC 875244
27 ex99-1_019.jpg GRAPHIC 935016
28 ex99-1_020.jpg GRAPHIC 844503
29 ex99-1_021.jpg GRAPHIC 856090
30 ex99-1_022.jpg GRAPHIC 1042511
31 ex99-1_023.jpg GRAPHIC 1219664
32 ex99-1_024.jpg GRAPHIC 1175885
33 ex99-1_025.jpg GRAPHIC 1140023
34 ex99-1_026.jpg GRAPHIC 1102693
35 ex99-1_027.jpg GRAPHIC 914589
36 ex99-1_028.jpg GRAPHIC 1282517
37 ex99-1_029.jpg GRAPHIC 1507667
38 ex99-1_030.jpg GRAPHIC 1027909
39 ex99-1_031.jpg GRAPHIC 908282
  Complete submission text file 0001493152-25-001567.txt   46507099

Data Files

Seq Description Document Type Size
40 XBRL SCHEMA FILE cldi-20250108.xsd EX-101.SCH 3813
41 XBRL DEFINITION FILE cldi-20250108_def.xml EX-101.DEF 30090
42 XBRL LABEL FILE cldi-20250108_lab.xml EX-101.LAB 36817
43 XBRL PRESENTATION FILE cldi-20250108_pre.xml EX-101.PRE 27113
54 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5755
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40789 | Film No.: 25520581
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)